The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Gene therapy with B7.1 and GM-CSF vaccines in a murine AML model.
K Dunussi-Joannopoulos; H J Weinstein; R J Arceci; J M Croop (Profiled Author: Robert Arceci)
Division of Pediatric Oncology, Dana Farber Cancer Institute, Children's Hospital, Boston, Massachusetts, USA.
Journal of pediatric hematology/oncology 1997;19(6):536-40.
PURPOSE: Characterization of B7.1 and GM-CSF vaccines on the induction of anti-tumor immunity in a murine AML model. MATERIALS AND METHODS: Primary AML cells were retrovirally transduced with the murine costimulatory molecule B7.1, a natural ligand for the T-cell receptors CD28 and CTLA-4, or the cytokine GM-CSF. Mice were vaccinated with irradiated AML cells expressing B7.1 or GM-CSF before or after inoculation of wild type AML cells. RESULTS: Intravenous injection of irradiated B7.1 or GM-CSF expressing AML cells can provide long lasting systemic immunity against a subsequent challenge of wild type AML cells. Vaccination with irradiated B7.1 or GM-CSF expressing AML cells results in rejection of established leukemia when the vaccination occurs in the early stages of the disease. However, when the vaccines are administered > 2 weeks after leukemic inoculation, only mice which receive the GM-CSF vaccine are cured of leukemia. CONCLUSIONS: These results suggest that tumor burden and vaccine efficiency are most likely to be the limiting factors in the curative potential of tumor vaccines. Novel approaches such as this experiment could provide improved therapeutic outcomes in patients with AML and other cancers.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
M C Thomas; T F Greten; D M Pardoll; E M JaffeeHuman gene therapy 1998;9(6):835-43.
E Y Chang; C H Chen; H Ji; T L Wang; K Hung; B P Lee; A Y Huang; R J Kurman; D M Pardoll; T WuInternational journal of cancer. Journal international du cancer 2000;86(5):725-30.
I Borrello; E M Sotomayor; S Cooke; H I LevitskyHuman gene therapy 1999;10(12):1983-91.
Appears in this Publication
Author of this Publication